Standard Operating Procedure for Reduction and Alkylation (if applicable) in Biosimilar Manufacturing

Department	Biosimilars
SOP No.	SOP/BS/185/2025
Supersedes	SOP/BS/185/2022
Page No.	Page 1 of 9
Issue Date	04/05/2025
Effective Date	06/05/2025
Review Date	04/05/2026

1. Purpose

To describe the procedure for performing controlled reduction and alkylation of biosimilar protein samples, typically for characterization or prior to protein refolding, ensuring consistent disulfide bond modification under GMP.

2. Scope

This SOP applies to biosimilar production batches or protein characterization samples requiring reduction (e.g., cleavage of disulfide bonds) and subsequent alkylation (e.g., cysteine modification) for analytical or preparative purposes.

3. Responsibilities

• Production: Perform reduction and alkylation as per process development instructions or batch record.
• QC/Analytical: Use reduced and alkylated samples for SDS-PAGE, peptide mapping, or mass spectrometry.
• QA: Ensure all operations are documented and validated per GMP standards.

4. Accountability

The Head of Downstream Manufacturing or Analytical Development is accountable for ensuring that reduction and alkylation are performed safely, reproducibly, and in compliance with regulatory expectations.

5. Procedure

5.1 Preparation

1. Confirm sample identity, protein concentration, and total volume.
2. Prepare fresh reducing agent (e.g., DTT or TCEP) and alkylating agent (e.g., iodoacetamide or IAM).
3. Ensure pH of buffer is suitable (typically pH 7.5–8.5) and reaction temperature is controlled (e.g., 25–37°C).

5.2 Reduction

1. Add reducing agent to protein solution to achieve final concentration (e.g., 5–10 mM DTT).
2. Incubate for 30–60 minutes at target temperature with gentle mixing.
3. Optional: verify disulfide bond cleavage by sampling for SDS-PAGE or RP-HPLC.

5.3 Alkylation

1. Protect samples from light (e.g., wrap in aluminum foil) if using light-sensitive alkylating agents.
2. Add alkylating agent (e.g., IAM) to final concentration of 15–25 mM.
3. React for 30 minutes at room temperature without agitation.
4. Quench reaction by adding molar excess of reducing agent or buffer exchange into suitable storage/formulation buffer.

5.4 Sample Handling and Storage

1. Store processed samples at 2–8°C if used immediately, or freeze at -20°C for long-term storage.
2. Label clearly with sample ID, treatment details, and operator initials.

5.5 Documentation

1. Record all reagent batch numbers, concentrations, and volumes in Annexure-1.
2. QC to confirm pH, appearance, and sample identity post-treatment.

6. Abbreviations

• DTT: Dithiothreitol
• TCEP: Tris(2-carboxyethyl)phosphine
• IAM: Iodoacetamide
• SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis

7. Documents

1. Reduction and Alkylation Log Sheet – Annexure-1
2. Sample Identification and Storage Record – Annexure-2

8. References

• ICH Q6B – Specifications: Test Procedures and Acceptance Criteria for Biotechnological Products
• WHO TRS 1004 – GMP Guidelines for Biotherapeutics
• FDA Guidance on Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Reduction and Alkylation Log Sheet

Date	Sample ID	Reducing Agent	Alkylating Agent	Incubation Temp	Remarks
04/05/2025	BS-RA-045	DTT 10 mM	IAM 20 mM	25°C	Clear, no precipitate

Annexure-2: Sample Identification and Storage Record

Sample ID	Treatment	Storage Temp	Location	Operator
BS-RA-045	Reduced & Alkylated	-20°C	Freezer Rack 3	Ajay Verma

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
04/05/2025	2.0	Added IAM concentration guidance and optional validation controls	Process harmonization